MacManus M, Fisher R, Roos D, O’Brien P, Macann A, Davis S et al (2018) Randomized trial of systemic therapy after involved-field radiotherapy in patients with early-stage follicular lymphoma: TROG 99.03. J Clin Oncol 36(29):2918–2925. https://doi.org/10.1200/JCO.2018.77.9892

Article  PubMed  CAS  Google Scholar 

Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A et al (2019) Definitive radiotherapy for localized follicular lymphoma staged by (18)F-FDG PET-CT: a collaborative study by ILROG. Blood 133(3):237–245. https://doi.org/10.1182/blood-2018-04-843540

Article  PubMed  CAS  Google Scholar 

Herfarth K, Borchmann P, Schnaidt S, Hohloch K, Budach V, Engelhard M et al (2018) Rituximab with involved field irradiation for early-stage nodal follicular lymphoma: results of the MIR Study. Hemasphere 2(6):e160. https://doi.org/10.1097/HS9.0000000000000160

Article  PubMed  PubMed Central  Google Scholar 

Ott OJ, Rodel C, Gramatzki M, Niedobitek G, Sauer R, Grabenbauer GG (2003) Radiotherapy for stage I–III nodal low-grade non-Hodgkin’s lymphoma. Strahlenther Onkol 179(10):694–701. https://doi.org/10.1007/s00066-003-1062-8

Article  PubMed  Google Scholar 

Dreyling M, Ghielmini M, Rule S, Salles G, Ladetto M, Tonino SH et al (2021) Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(3):298–308. https://doi.org/10.1016/j.annonc.2020.11.008

Article  PubMed  CAS  Google Scholar 

Wirth A, Mikhaeel NG, Aleman BMP, Pinnix CC, Constine LS, Ricardi U et al (2020) Involved site radiation therapy in adult lymphomas: an overview of international lymphoma radiation oncology group guidelines. Int J Radiat Oncol Biol Phys 107(5):909–933. https://doi.org/10.1016/j.ijrobp.2020.03.019

Article  PubMed  Google Scholar 

Campbell BA, Voss N, Woods R, Gascoyne RD, Morris J, Pickles T et al (2010) Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy. Cancer 116(16):3797–3806. https://doi.org/10.1002/cncr.25117

Article  PubMed  Google Scholar 

Yu JI, Nam H, Ahn YC, Kim WS, Park K, Kim SJ (2010) Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma. Int J Radiat Oncol Biol Phys 78(2):507–512. https://doi.org/10.1016/j.ijrobp.2009.07.1706

Article  PubMed  Google Scholar 

Verhappen MH, Poortmans PM, Raaijmakers E, Raemaekers JM (2013) Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin’s lymphoma. Radiother Oncol 109(1):133–139. https://doi.org/10.1016/j.radonc.2013.07.013

Article  PubMed  Google Scholar 

Wohrer S, Jaeger U, Kletter K, Becherer A, Hauswirth A, Turetschek K et al (2006) 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol 17(5):780–784. https://doi.org/10.1093/annonc/mdl014

Article  PubMed  CAS  Google Scholar 

Luminari S, Biasoli I, Arcaini L, Versari A, Rusconi C, Merli F et al (2013) The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Ann Oncol 24(8):2108–2112. https://doi.org/10.1093/annonc/mdt137

Article  PubMed  CAS  Google Scholar 

Wirth A, Foo M, Seymour JF, Macmanus MP, Hicks RJ (2008) Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma. Int J Radiat Oncol Biol Phys 71(1):213–219. https://doi.org/10.1016/j.ijrobp.2007.09.051

Article  PubMed  Google Scholar 

Karsten IE, Reinartz G, Pixberg M, Kröger K, Oertel M, Friedrichs B et al (2021) Radiotherapy in follicular lymphoma staged by 18F-FDG-PET/CT: a German monocenter study. Biomedicines 9(5):561. https://doi.org/10.3390/biomedicines9050561

Article  PubMed  PubMed Central  CAS  Google Scholar 

Konig L, Dreyling M, Durig J, Engelhard M, Hohloch K, Viardot A et al (2019) Therapy of nodal follicular lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted involved site radiotherapy in combination with Obinutuzumab (Gazyvaro)—GAZAI trial (GAZyvaro and response adapted involved-site radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial. Trials 20(1):544. https://doi.org/10.1186/s13063-019-3614-y

Article  PubMed  PubMed Central  CAS  Google Scholar 

Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32(27):3048–3058. https://doi.org/10.1200/JCO.2013.53.5229

Article  PubMed  PubMed Central  Google Scholar 

Armitage JO (2005) Staging non-Hodgkin lymphoma. CA Cancer J Clin 55(6):368–376. https://doi.org/10.3322/canjclin.55.6.368

Article  PubMed  Google Scholar 

Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059–3068. https://doi.org/10.1200/JCO.2013.54.8800

Article  PubMed  PubMed Central  Google Scholar 

Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L et al (2014) Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 89(1):49–58. https://doi.org/10.1016/j.ijrobp.2014.01.006

Article  PubMed  Google Scholar 

Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A et al (2021) Value of PET imaging for radiation therapy. Nuklearmedizin 60(5):326–343. https://doi.org/10.1055/a-1525-7029

Article  PubMed  Google Scholar 

Kwee TC, Kwee RM, Nievelstein RA (2008) Imaging in staging of malignant lymphoma: a systematic review. Blood 111(2):504–516. https://doi.org/10.1182/blood-2007-07-101899

Article  PubMed  CAS  Google Scholar 

Konig L, Herfarth K, Horner-Rieber J, Dietrich S, Wiegel T, Debus J et al (2020) Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma. Strahlenther Onkol 196(8):705–714. https://doi.org/10.1007/s00066-020-01624-w

Article  PubMed  PubMed Central  Google Scholar 

Engelhard M, Unterhalt M, Hansmann ML, Stuschke M, Indole R‑TN (2013) Follicular lymphoma: final results of the randomized evaluation of curative radiotherapy in limited stage nodal disease. Strahlenther Onkol 189:36

Google Scholar 

Kriz J, Reinartz G, Dietlein M, Kobe C, Kuhnert G, Haverkamp H et al (2015) Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys 92(1):46–53. https://doi.org/10.1016/j.ijrobp.2015.01.048

Article  PubMed  Google Scholar 

Bird D, Patel C, Scarsbrook AF, Cosgrove V, Thomas E, Gilson D et al (2017) Evaluation of clinical target volume expansion required for involved site neck radiotherapy for lymphoma to account for the absence of a pre-chemotherapy PET-CT in the radiotherapy treatment position. Radiother Oncol 124(1):161–167. https://doi.org/10.1016/j.radonc.2017.05.014

Article  PubMed  Google Scholar 

Aznar MC, Girinsky T, Berthelsen AK, Aleman B, Beijert M, Hutchings M et al (2017) Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group. Acta Oncol 56(4):608–613. https://doi.org/10.1080/0284186X.2017.1279750

Article  PubMed  Google Scholar